Press Release Distribution
 

Members Login  |  Register  |  Why Join?   Subscribe to Newsletter Newsletter   RSS Feeds RSS Feeds

Video Releases    |    Pricing & Distribution Plans    |    Today's News    |    News By Category    |    News By Date    |    Business Directory
All Press Releases for February 10, 2012 »
RSS Feeds RSS Feed     Print this news Printer Friendly     Email this news Email It    Create PDF PDF Version    Bookmark del.icio.us    Diggs



Jürgen Frisch appointed Chief Medical Officer of European Operations at Clinipace Worldwide
Distinguished Physician and Life Science Executive to Lead European-Based Medical and Regulatory Teams While Providing Expert Guidance and Advisory Services to Clients Worldwide 
x-small text small text medium text large text


    ZURICH, SWITZERLAND, February 10, 2012 /24-7PressRelease/ -- Clinipace Worldwide, a global digital contract research organization (dCRO) that has pioneered technology-amplified contract research services, announced today the appointment of Jürgen Frisch, MD, to Chief Medical Officer of European Operations.

In this position, Jürgen is responsible for providing leadership and direction to the medical and regulatory service groups within the European Operations at Clinipace Worldwide. Jürgen is based in the Zurich office.

Over his long and distinguished career, Jürgen held several senior medical and management positions at multinational pharmaceutical and biotechnology companies, including Eidetica Biopharma GmbH (a subsidiary of Biogen Idec), immatics biotechnologies GmbH, Intercell AG, Genetics Institute GmbH, HMR Hoechst Marion Roussel GmbH, and Behringwerke AG. Prior to joining Clinipace Worldwide, Jürgen served as a medical reviewer at Swissmedic (Medical Health Authority) in Bern, Switzerland.

Jürgen completed his Medical Doctorate in Internal Medicine at the Johannes Gutenberg University of Mainz, served on the faculty of Medicine in Mainz; and is Board Certified in Internal Medicine.

"With Jürgen's expertise as a researcher and drug developer, clients worldwide will receive the very best guidance and advisory services for their drug development programs," said Kurt Pfister, CEO of European Operations at Clinipace Worldwide.

About Clinipace Worldwide
As a global full-service digital contract research organization (dCRO), we have pioneered an innovative technology-amplified research model to serve the unique needs of emerging and mid-tier biopharmaceutical and medical device firms. Powered by TEMPO , our proprietary eClinical platform, our team of experts brings extensive therapeutic knowledge and insight into assisting life science firms in developing and executing regulatory strategies, clinical development, and post-approval research to ensure a successful drug and medical device development program. We have managed over 600 global contract research and regulatory projects. Clinipace Worldwide is headquartered in ResearchTriangle Park, North Carolina with offices in Boulder, Overland Park, Zurich, Munich, Tel-Aviv, Sao Paulo, Buenos Aires, Lima, and New Delhi. For more information visit our website at http://www.clinipace.com.

Media Contact:
Molly Thompson
mthompson [at] crossroadspr dot com
919.821.2822


---
Press release service and press release distribution provided by http://www.24-7pressrelease.com


# # #



Press Release Service & Press Release Distribution News Supplied By 24-7PressRelease.com
Press Release Contact Information:
Michele Chandler
Crossroads Public Relations

Account Coordinator
4030 Wake Forest Rd.
Raleigh, North Carolina
United States 27606
Voice: 9198212822
E-Mail: Email us Here
Website: Visit Our Website
Disclaimer:
If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7 Press Release. We are unable to assist you with any information regarding this release. 24-7 Press Release disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.